The University of Chicago Header Logo

Connection

Robert Shenkar to Class I Phosphatidylinositol 3-Kinases

Back to Details
This is a "connection" page, showing publications Robert Shenkar has written about Class I Phosphatidylinositol 3-Kinases.
Robert Shenkar
Connection Strength
0.644
Class I Phosphatidylinositol 3-Kinases
  1. Growth of PIK3CA-driven cerebral cavernous malformations does not require microbiome stimulation. JCI Insight. 2026 Sep 08; 11(17).
    View in: PubMed
    Score: 0.235
  2. mTORC1 Inhibitor Rapamycin Inhibits Growth of Cerebral Cavernous Malformation in Adult Mice. Stroke. 2023 11; 54(11):2906-2917.
    View in: PubMed
    Score: 0.194
  3. PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism. Nature. 2021 06; 594(7862):271-276.
    View in: PubMed
    Score: 0.164
  4. Except for Robust Outliers, Rapamycin Increases Lesion Burden in a Murine Model of Cerebral Cavernous Malformations. Transl Stroke Res. 2025 Jun; 16(3):859-867.
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.